首页> 美国卫生研究院文献>Neuro-Oncology >ACTR-72. A PROSPECTIVE PHASE II RANDOMIZED TRIAL TO COMPARE INTENSITY MODULATED PROTON RADIOTHERAPY (IMPT) VS. INTENSITY MODULATED RADIOTHERAPY (IMRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

【2h】

ACTR-72. A PROSPECTIVE PHASE II RANDOMIZED TRIAL TO COMPARE INTENSITY MODULATED PROTON RADIOTHERAPY (IMPT) VS. INTENSITY MODULATED RADIOTHERAPY (IMRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

机译：ACTR-72。预期第二阶段随机试验用于比较强度调制的质子放射治疗（IMPT）与新诊断的胶质母细胞瘤（GBM）的强度调制放射疗法（IMRT）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PURPOSETo determine if IMPT compared to IMRT delayed time to cognitive failure in patients with newly diagnosed GBM.

机译：目的确定与IMRT相比IMPT是否能延迟新诊断为GBM的患者的认知衰竭时间。

著录项

期刊名称 Neuro-Oncology
作者
Caroline Chung; Paul D Brown; Sarah McAvoy; David R Grosshans; Seyedeh Dibaj; Nandita Guha-Thakurta; Jing Li; Susan L McGovern; Mary Fran Mcaleer; Amol Ghia; Arnold Paulino; Erik Sulman; Marta Penas-Prado; Jihong Wang; John de Groot; Amy Heimberger; Terri S Armstrong; Mark R Gilbert; Anita Mahajan; Jeffrey Wefel;
展开▼
作者单位

展开▼
年(卷),期 2017(19),Suppl 6
年度 2017
页码 vi16
总页数 1
原文格式 PDF
正文语种
中图分类神经病学;肿瘤学;
关键词

相似文献

外文文献
专利

1. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials [J] . Carlson Julie A., Reddy Krishna, Gaspar Laurie E., Journal of neuro-oncology. . 2015,第2期

机译：超低强度调强放疗（hypo-IMRT）和替莫唑胺（TMZ）联合或不联合贝伐单抗（BEV）用于新诊断的胶质母细胞瘤（GBM）：两项前瞻性II期临床试验的比较
2. A prospective phase Ⅱ randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma [J] . Brown Paul D., Chung Caroline, Liu Diane D., Neuro-Oncology . 2021,第8期

机译：新诊断胶质母细胞瘤患者质子放射治疗的预期Ⅱ期随机试验对强度调节放射治疗
3. Prospective Phase II Randomized Trial Comparing Proton Therapy vs. IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free Survival between Clinical Radiological Assessment vs. Response Assessment in Neuro-Oncology (RANO) [J] . Al Feghali K. A., Randall J. W., Wefel J. S., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：预期第II期随机试验比较质子疗法对新诊断的GBM：临床放射性评估与临床放射性评估之间进展比较的二次分析比较。临床放射性评估与神经肿瘤学中的反应评估（RANO）
4. Comparative analysis of Volumetric Modulated Arc Radiotherapy (VMAT) versus Intensity Modulated Radiotherapy (IMRT) Using the TG119 Tests [C] . Milton E. Ixquiac Cabrera, Erick O. Montenegro, Juan F. Lucero, World Congress on Medical Physics and Biomedical Engineering . 2013

机译：使用TG119测试对体积调制弧线放射疗法（VMAT）与强度调制放射线疗法（IMRT）的比较分析
5. Modeling secondary cancer risk following paediatric radiotherapy: a comparison of intensity modulated proton therapy and photon therapy. [D] . Shin, Naomi. 2012

机译：儿科放射治疗后的继发性癌症风险建模：强度调制质子治疗与光子治疗的比较。
6. RTHP-18. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR NEWLY DIAGNOSED GBM: SECONDARY ANALYSIS COMPARISON OF GENDER AND NEUTROPHIL-LYMPHOCYTE RATIO (NLR) IN GBM OUTCOMES [O] . James Randall, Karine Al Feghali, Jeffrey Wefel, 2019

机译：RTHP-18。预期期II型随机试验比较质子疗法与用于新诊断的GBM的光子IMRT：GBM结果中性别和中性粒细胞淋巴细胞比（NLR）的二次分析比较
7. Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiotherapy (IMRT) for Patients with Stage III Non-Small Cell Lung Cancer: First Comparative Results of Patient-Reported Outcomes (PRO) [O] . N.Y. Yu, T.A. DeWees, W. Breen, 2019

机译：强度调制的质子疗法（IMPT）对III期阶段非小细胞肺癌患者的强度调节放疗（IMRT）：患者报告的结果的第一个比较结果（Pro）

ACTR-72. A PROSPECTIVE PHASE II RANDOMIZED TRIAL TO COMPARE INTENSITY MODULATED PROTON RADIOTHERAPY (IMPT) VS. INTENSITY MODULATED RADIOTHERAPY (IMRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

摘要

著录项

相似文献

相关主题

期刊订阅